2 hours Leerink Partnrs Issues Pessimistic Outlook for NBIX EarningsMarketBeat
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) – Investment analysts at Leerink Partnrs decreased their Q3 2024 earnings per share (EPS) estimates for shares of Neurocrine Biosciences in a report issued on Tuesday, October 15th. Leerink Pa…
X